Subcutaneous amikacin administration in red-eared sliders (Trachemys scripta elegans) produces prolonged detectable plasma concentrations without biochemistry evidence of impaired renal function
American Journal of Veterinary Research · 2024
DOI: 10.2460/ajvr.24.03.0088 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Veterinary Research, 2024. Verfasst von Kara Hiebert und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI. Hauptthemen laut MEDLINE: Amikacin, Anti-Bacterial Agents, Turtles. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
OBJECTIVE To establish pilot data on the plasma concentrations of SC amikacin at 2 doses in red-eared sliders and evaluate concurrent plasma biochemistry parameters. ANIMALS 8 adult red-eared sliders ( Trachemys scripta elegans ). METHODS Amikacin was administered SC at target doses of 5 and 10 mg/kg with a 3-week washout period. Blood samples were collected at 0, 24, 48, 72, and 96 hours postadministration. Plasma amikacin concentrations were quantified using liquid chromatography tandem mass spectrometry. Plasma biochemistry analyses were performed before amikacin administration, 1 week post 5-mg/kg administration, and 1 week post 10-mg/kg administration. RESULTS Mean maximum amikacin plasma concentrations were recorded 24 hours after 5-mg/kg and 10-mg/kg dosing and were 17.5 ± 2.32 µg/mL and 23.6 ± 2.92 µg/mL, respectively. Mean plasma concentrations after 5-mg/kg dosing steadily decreased to 9.1 ± 0.92 µg/mL by 96 hours postadministration. Amikacin remained detectable in all plasma samples 3 weeks post 5-mg/kg dosing with a mean plasma concentration of 1.04 ± 0.22 µg/mL. Mean plasma concentrations after 10-mg/kg dosing did not decrease over the 96-hour study period. There were no clinically relevant changes in biochemistry parameters. CLINICAL RELEVANCE Amikacin persists at detectable plasma levels for at least 3 weeks after SC administration of a 5-mg/kg dose in red-eared sliders, which has not previously been reported in any species. No biochemistry changes consistent with renal toxicity occurred after either dose. Use caution with repeated amikacin dosing in this species until further studies can better characterize cumulative amikacin pharmacokinetics and toxic threshold.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgical Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI.
- KL Maddy Equine Analytical Pharmacology Lab, School of Veterinary Medicine, University of California-Davis, Davis, CA.
Zitieren
APA
Hiebert, K., Knych, H., & Hawkins, S. (2024). Subcutaneous amikacin administration in red-eared sliders (Trachemys scripta elegans) produces prolonged detectable plasma concentrations without biochemistry evidence of impaired renal function. American Journal of Veterinary Research. https://doi.org/10.2460/ajvr.24.03.0088
Vancouver
Hiebert K, Knych H, Hawkins S. Subcutaneous amikacin administration in red-eared sliders (Trachemys scripta elegans) produces prolonged detectable plasma concentrations without biochemistry evidence of impaired renal function. American Journal of Veterinary Research. 2024. doi:10.2460/ajvr.24.03.0088
BibTeX
@article{Hiebert2024,
author = {Hiebert, Kara and Knych, Heather and Hawkins, Shawna},
title = {Subcutaneous amikacin administration in red-eared sliders (Trachemys scripta elegans) produces prolonged detectable plasma concentrations without biochemistry evidence of impaired renal function},
journal = {American Journal of Veterinary Research},
year = {2024},
doi = {10.2460/ajvr.24.03.0088}
}
EUVIMED